World's Best Scientists 2026 revealed!
Kai W. Wucherpfennig

Kai W. Wucherpfennig

D-Index & Metrics

Immunology

D-Index
113
Citations
51269
World Ranking
428
National Ranking
262

Medicine

D-Index
113
Citations
51269
World Ranking
4919
National Ranking
2665

Kai W. Wucherpfennig publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Kai W. Wucherpfennig sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 348 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Kai W. Wucherpfennig D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Kai W. Wucherpfennig sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 113 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2009 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Kai W. Wucherpfennig is affiliated with Harvard University in the United States. Their research primarily spans the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Within these areas, their subfields of study include Oncology, Immunology, Molecular Biology, Genetics, and Hematology.

The scientist's work addresses several key topics including CAR-T cell therapy research, immune cell function and interaction, cancer immunotherapy and biomarkers, immunotherapy and immune responses, immune cells in cancer, T-cell and B-cell immunology, and the application of single-cell and spatial transcriptomics technologies.

Frequent venues for their publications feature a significant concentration in journals such as Blood, Cell, Cancer Research, Regular and Young Investigator Award Abstracts, and Cancer Cell. These venues reflect the focus on hematology, oncology, and immunology research.

Recent papers represent major contributions with a focus on cancer immunology and cellular interactions, including:

  • Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma (2021, Cancer Cell)
  • Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma (2021, Nature Medicine)
  • Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy (2020, Cell)
  • Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis (2021, Cell)
  • Distinct Mesenchymal Cell Populations Generate the Essential Intestinal BMP Signaling Gradient (2020, Cell Stem Cell)

Their frequent co-authors include:

  • Jason W. Pyrdol
  • Nathan D. Mathewson
  • Adrienne Luoma
  • Mario L. Suvà
  • Aviv Regev

Kai W. Wucherpfennig's scholarly activity includes a wide array of publications in high-impact journals and repeated collaboration with established researchers in their field. Their work intersects immunological mechanisms and cancer biology, with a focus on how immune responses can be modulated to influence cancer progression and treatment outcomes.

They received recognition as a Fellow of the American Association for the Advancement of Science (AAAS) in 2009.

Best Publications

  • Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

    Peng Jiang;Shengqing Gu;Deng Pan;Jingxin Fu

  • An immunogenic personal neoantigen vaccine for patients with melanoma

    Patrick A. Ott;Zhuting Hu;Derin B. Keskin;Derin B. Keskin;Sachet A. Shukla;Sachet A. Shukla

  • Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein

    Kai W Wucherpfennig;Jack L Strominger

  • A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

    Livnat Jerby-Arnon;Parin Shah;Michael S. Cuoco;Christopher Rodman

  • Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

    Derin B. Keskin;Annabelle J. Anandappa;Jing Sun;Itay Tirosh

  • Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation

    Thomas Korn;Jayagopala Reddy;Wenda Gao;Estelle Bettelli

  • Radiotherapy induces responses of lung cancer to CTLA-4 blockade

    Silvia C. Formenti;Nils Petter Rudqvist;Encouse Golden;Encouse Golden;Benjamin Cooper

  • A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing

    Deng Pan;Aya Kobayashi;Aya Kobayashi;Peng Jiang;Lucas Ferrari de Andrade

  • MHC-II neoantigens shape tumour immunity and response to immunotherapy

    Elise Alspach;Danielle M. Lussier;Alexander P. Miceli;Ilya Kizhvatov

  • A functional and structural basis for TCR cross-reactivity in multiple sclerosis

    Heather L.E. Lang;Helle Jacobsen;Helle Jacobsen;Shinji Ikemizu;Christina Andersson;Christina Andersson

  • Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

    Mariella G. Filbin;Itay Tirosh;Itay Tirosh;Volker Hovestadt;Volker Hovestadt;McKenzie L. Shaw;McKenzie L. Shaw

  • Deconstructing the Peptide-MHC Specificity of T Cell Recognition

    Michael E. Birnbaum;Juan L. Mendoza;Dhruv K. Sethi;Shen Dong

  • The Organizing Principle in the Formation of the T Cell Receptor-CD3 Complex

    Matthew E. Call;Jason Pyrdol;Martin Wiedmann;Kai W. Wucherpfennig

  • Mechanisms for the induction of autoimmunity by infectious agents

    Kai W. Wucherpfennig

  • Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma.

    Toshiro Hara;Rony Chanoch-Myers;Nathan D. Mathewson;Nathan D. Mathewson;Chad Myskiw

  • Regulation of T Cell Receptor Activation by Dynamic Membrane Binding of the CD3ɛ Cytoplasmic Tyrosine-Based Motif

    Chenqi Xu;Etienne Gagnon;Matthew E. Call;Jason R. Schnell

  • Th17 Cells Induce Ectopic Lymphoid Follicles in Central Nervous System Tissue Inflammation

    Anneli Peters;Lisa A. Pitcher;Jenna M. Sullivan;Meike Mitsdoerffer

  • Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein

    Kai W. Wucherpfennig;Kohei Ota;Noriaki Endo;J. G. Seidman

  • Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma

    Zhuting Hu;Donna E. Leet;Rosa L. Allesøe;Giacomo Oliveira

  • Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes

    Kon Ho Lee;Kai W. Wucherpfennig;Don C. Wiley;Don C. Wiley

  • Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse

    Kaushik Choudhuri;Jaime Llodrá;Eric W. Roth;Jones Tsai

  • Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein

    Kathrine J. Smith;Jason Pyrdol;Laurent Gauthier;Don C. Wiley

Frequent Co-Authors

David A. Hafler
David A. Hafler Yale University
Jack L. Strominger
Jack L. Strominger Harvard University
Nir Hacohen
Nir Hacohen Harvard University
Aviv Regev
Aviv Regev Genentech
Itay Tirosh
Itay Tirosh Weizmann Institute of Science
Michael C. Carroll
Michael C. Carroll Boston Children's Hospital
Scott J. Rodig
Scott J. Rodig Harvard University
Vijay K. Kuchroo
Vijay K. Kuchroo Harvard University
David A. Reardon
David A. Reardon Harvard University
Keith L. Ligon
Keith L. Ligon Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals transition into advanced nursing roles, such as Nurse Practitioners, where specialized knowledge in immunology is highly valuable.

If you're a Family Nurse Practitioner (FNP) considering specialization, an fnp to acnp bridge program online offers a streamlined path to become an Acute Care Nurse Practitioner. These programs balance flexibility and advanced clinical training, ideal for working professionals.

Accelerated pathways also exist for individuals aiming to enter nursing swiftly. The nurse practitioner accelerated program is designed to expedite education while maintaining quality, preparing students for direct patient care roles that often engage immunology expertise.

For non-nurses seeking entry into the healthcare field, online absn programs for non nurses provide an accessible route to obtain a Bachelor of Science in Nursing. This foundation can later be built upon for specialization in immunology-related careers.

Understanding salary variations is also crucial when planning your education and career. Resources detailing dnp salary by specialty help in making informed decisions aligned with market trends and personal goals.

Best Scientists Citing Kai W. Wucherpfennig

Trending Scientists

Recently Published Articles